U.S., Sept. 30 -- ClinicalTrials.gov registry received information related to the study (NCT07196358) titled 'Topical Heparin for Prevention of Hypertrophic Scarring in Split-Thickness Skin Graft Donor Sites' on Sept. 21.
Brief Summary: This study is testing whether applying a special dressing soaked with heparin (a medicine that improves blood flow and reduces scar formation) can help prevent thick, raised scars (called hypertrophic scars) and reduce pain at the site where skin is taken for a split-thickness skin graft. When people need skin grafts for burns, injuries, or other conditions, the area where the skin is taken (donor site) can sometimes heal with painful or raised scars. In this study, each patient will have one donor site tre...